AB
COGT icon

Amalgamated Bank’s Cogent Biosciences COGT Stock Holding History

Amalgamated Bank’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,367
Closed -$155K – 1892
2025
Q4 		$155K Buy
4,367
+1,189
+37% +$33.4K ﹤0.01% 1622
2025
Q3 		$46K Hold
3,178
– – ﹤0.01% 1863
2025
Q2 		$23K Hold
3,178
– – ﹤0.01% 2055
2025
Q1 		$19K Buy
3,178
+354
+13% +$2.77K ﹤0.01% 2065
2024
Q4 		$22K Hold
2,824
– – ﹤0.01% 2079
2024
Q3 		$30K Hold
2,824
– – ﹤0.01% 1993
2024
Q2 		$24K Hold
2,824
– – ﹤0.01% 2052
2024
Q1 		$19K Sell
2,824
-6,793
-71% -$42K ﹤0.01% 2144
2023
Q4 		$57K Buy
9,617
+534
+6% +$4.09K ﹤0.01% 2185
2023
Q3 		$89K Buy
9,083
+400
+5% +$4.74K ﹤0.01% 2040
2023
Q2 		$103K Buy
8,683
+1,977
+29% +$22.7K ﹤0.01% 2050
2023
Q1 		$72K Sell
6,706
-1,563
-19% -$20K ﹤0.01% 2167
2022
Q4 		$96K Hold
8,269
– – ﹤0.01% 2149
2022
Q3 		$123K Buy
8,269
+2,601
+46% +$35.7K ﹤0.01% 2058
2022
Q2 		$51K Buy
5,668
+726
+15% +$4.96K ﹤0.01% 2470
2022
Q1 		$37K Buy
+4,942
New +$34.4K ﹤0.01% 2599

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Amalgamated Bank's COGT Position: Q1 2026 in Review

Amalgamated Bank sold out of Cogent Biosciences (COGT) in Q1 2026, closing a stake of 4,367 shares — an estimated $155K sold.

Amalgamated Bank first reported a position in COGT in Q1 2022 and held it in 16 quarters. The position peaked at $155K in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Amalgamated Bank reported no remaining Cogent Biosciences position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 4,367 Cogent Biosciences shares in Q1 2026, an estimated $155K.
  • Amalgamated Bank first reported a position in Cogent Biosciences in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Cogent Biosciences position peaked at $155K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.